HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF SEPSIS SYNDROME

被引：4
|
作者：
TOMPKINS, RG
机构：
来源：
CRITICAL CARE MEDICINE | 1994年 / 22卷 / 01期
关键词：
INTERLEUKIN-1; SEPSIS; CYTOKINES; PATIENT OUTCOME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;
D O I：
10.1097/00003246-199401000-00002
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] Heterogeneous Treatment Effect Of Recombinant Human Interleukin-1 Receptor Antagonist For Human Severe Sepsis
    Meyer, N. J.
    Dunn, T. G.
    Reilly, J. P.
    Palakshappa, J. A.
    Feng, R.
    Christie, J. D.
    Palardy, J. E.
    Opal, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
    Meyer, Nuala J.
    Reilly, John P.
    Anderson, Brian J.
    Palakshappa, Jessica A.
    Jones, Tiffanie K.
    Dunn, Thomas G.
    Shashaty, Michael G. S.
    Feng, Rui
    Christie, Jason D.
    Opal, Steven M.
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 21 - 28
  • [3] RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994)
    FISHER, CJ
    DHAINAUT, JFA
    OPAL, SM
    PRIBBLE, JP
    BALK, RA
    SLOTMAN, GJ
    IBERTI, TJ
    RACKOW, EC
    SHAPIRO, MJ
    GREENMAN, RL
    REINES, HD
    SHELLY, MP
    THOMPSON, BW
    LABRECQUE, JF
    CATALANO, MA
    KNAUS, WA
    SADOFF, JC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15): : 1170 - 1170
  • [4] Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    Bresnihan, B
    Alvaro-Gracia, JM
    Cobby, M
    Doherty, M
    Domljan, Z
    Emery, P
    Nuki, G
    Pavelka, K
    Rau, R
    Rozman, B
    Watt, I
    Williams, B
    Aitchison, R
    McCabe, D
    Musikic, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (12): : 2196 - 2204
  • [5] Interleukin-1 Receptor Antagonist treatment in Schnitzler syndrome
    Land, M.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A68 - A68
  • [6] Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome
    Samson, LM
    Allen, UD
    Creery, WD
    DiazMitoma, F
    Singh, RN
    JOURNAL OF PEDIATRICS, 1997, 131 (04): : 587 - 591
  • [7] ROLE OF INTERLEUKIN-1 AND THE THERAPEUTIC POTENTIAL OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN SEPSIS
    FISHER, CJ
    OPAL, SM
    LOWRY, SF
    SADOFF, JC
    LABRECQUE, JF
    DONOVAN, HC
    LOOKABAUGH, JL
    LEMKE, J
    PRIBBLE, JP
    STROMATT, SC
    VIGERS, GP
    RUSSELL, DA
    THOMPSON, RC
    CIRCULATORY SHOCK, 1994, 44 (01) : 1 - 8
  • [8] Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist
    Yu, Pengzhan
    Zheng, Chunyang
    Chen, Jing
    Zhang, Guifeng
    Liu, Yongdong
    Suo, Xiaoyan
    Zhang, Guicai
    Su, Zhiguo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (16) : 5396 - 5405
  • [9] COMPARATIVE RESPONSES OF HUMAN AND RABBIT INTERLEUKIN-1 INVIVO - EFFECT OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST
    VONUEXKULL, C
    NOURSHARGH, S
    WILLIAMS, TJ
    IMMUNOLOGY, 1992, 77 (04) : 483 - 487
  • [10] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
12345